BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7189572)

  • 1. [Long-term treatment of thrombocytosis and thrombocythemia].
    Linker H; Lindner HJ; Reuter H; Gross R
    Med Welt; 1980 Apr; 31(14):509-12. PubMed ID: 7189572
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anagrelide in the treatment of essential thrombocythemia (ET) and other myeloproliferative disorders with thrombocythemia based on data from patient register in the CR].
    Penka M; Doubek M; Schwarz J; Pytlík R; Dulícek P; Kissová J; Hlusí A; Vozobulová V; Cerná O; Brychtová Y; Szotkowski T; Volková Z; Seghetová J; Schutzová M; Hadacová I; Hochová I; Voglová J; Siroký O; Belada D; Lhot'anová T; Bubeník B; Vránová M; Micaníková M; Dusek L
    Vnitr Lek; 2006 May; 52(5):498-503. PubMed ID: 16771099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytosis and thrombocythemia.
    Schafer AI
    Blood Rev; 2001 Dec; 15(4):159-66. PubMed ID: 11792116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of human prothrombin and fibrinogen in patients with thrombocytosis secondary to myeloproliferative states.
    Martinez J; Shapiro SS; Holburn RR
    Blood; 1973 Jul; 42(1):35-46. PubMed ID: 4736876
    [No Abstract]   [Full Text] [Related]  

  • 5. [Megakaryocytic pseudomyelosis with severe thrombocytosis].
    Krug K; Rohrberg R; Wessel H
    Z Gesamte Inn Med; 1981 Oct; 36(19):734-7. PubMed ID: 6171109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The results of patients with essentials thrombocythemia and other myeloproliferation-related thrombocythemia--a report of patients treated with Thromboreductin].
    Penka M; Schwarz J; Pavlík T; Indrák K; Doubek M; Dulícek P; Pospísilová D; Kissová J; Jonásová A; Jelínková P; Hlusí A; Schutzová M; Cerná O; Brychtová Y; Nováková L; Korístek Z; Segethová J; Vozobulová V; Hadacová I; Hochová I; Voglová J; Walterová L; Bodzásová C; Dusek L
    Vnitr Lek; 2009 Nov; 55(11):I-XII. PubMed ID: 20017445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and treatment of essential thrombocythemia].
    Kuramoto A
    Rinsho Ketsueki; 1995 May; 36(5):480-6. PubMed ID: 7783354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential thrombocythemia: a relative benign long-term course.
    Meisel S; Shpilberg O; Ramot B; Ben-Bassat I
    Isr J Med Sci; 1993 Apr; 29(4):190-4. PubMed ID: 8491569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of elderly patients with myeloproliferative disorders.
    Tura S
    Hematol Oncol; 1993; 11 Suppl 1():39-41. PubMed ID: 8486340
    [No Abstract]   [Full Text] [Related]  

  • 10. [Essential thrombocytosis. Presentation of one case (author's transl)].
    Jeri A; Horna E; Rojas M
    Sangre (Barc); 1975; 20(1):63-8. PubMed ID: 1168376
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombocytosis. A source of increased bleeding tendency.
    Solhaug JH
    Acta Chir Scand; 1973; 139(3):225-7. PubMed ID: 4735419
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders.
    Randi ML; Ruzzon E; Luzzatto G; Tezza F; Girolami A; Fabris F
    Haematologica; 2005 Feb; 90(2):261-2. PubMed ID: 15710584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrimethamine in the myeloproliferative disorders: a forgotten treatment?
    Bowcock SJ; Linch DC; Machin SJ; Stewart JW
    Clin Lab Haematol; 1987; 9(2):129-36. PubMed ID: 3621857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombocytosis and thrombocythemia].
    Lefrère JJ; Samama M
    Rev Med Interne; 1985 Jun; 6(3):285-90. PubMed ID: 4048690
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful pregnancies after recurrent abortions in mild essential thrombocythemia.
    Kaaja RJ; Leinonen PJ
    Acta Obstet Gynecol Scand; 1998 Nov; 77(10):1022-3. PubMed ID: 9849849
    [No Abstract]   [Full Text] [Related]  

  • 16. Busulphan is safe and efficient treatment in elderly patients with essential thrombocythemia.
    Shvidel L; Sigler E; Haran M; Klepfish A; Duek A; Berrebi A; Shtalrid M
    Leukemia; 2007 Sep; 21(9):2071-2. PubMed ID: 17611572
    [No Abstract]   [Full Text] [Related]  

  • 17. [A patient with primary thrombocythemia].
    Dullemond-Westland AC; van Toorn DW
    Ned Tijdschr Geneeskd; 1985 Apr; 129(16):748-50. PubMed ID: 3990874
    [No Abstract]   [Full Text] [Related]  

  • 18. [Essential thrombocythemia. Apropos of 3 cases].
    Sanz Marca A; Rico Pérez MT; Aboín Massieu FJ; Rebollar Mesa JL
    Rev Clin Esp; 1983 Mar; 168(5):347-50. PubMed ID: 6683423
    [No Abstract]   [Full Text] [Related]  

  • 19. Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future studies.
    Landolfi R; Di Gennaro L; Novarese L; Patrono C
    Semin Thromb Hemost; 2006 Apr; 32(3):251-9. PubMed ID: 16673279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Essential thrombocythemia].
    Torre López E
    Rev Invest Clin; 1995; 47(1):83-4. PubMed ID: 7777720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.